2016 Oct 4. doi: 10.1038/mp.2016.156. [Epub ahead of print]
Lange MD1, Daldrup T1, Remmers F2, Szkudlarek HJ1, Lesting J1, Guggenhuber S2, Ruehle S2, Jüngling K1, Seidenbecher T1, Lutz B2, Pape HC1.
Abstract
The brain circuits underlying behavioral fear have been extensively studied over the last decades. Although the vast majority of experimental studies assess fear as a transient state of apprehension in response to a discrete threat, such phasic states of fear can shift to a sustained anxious apprehension, particularly in face of diffuse cues with unpredictable environmental contingencies. Unpredictability, in turn, is considered an important variable contributing to anxiety disorders. The networks of the extended amygdala have been suggested keys to the control of phasic and sustained states of fear, although the underlying synaptic pathways and mechanisms remain poorly understood. Here, we show that the endocannabinoid system acting in synaptic circuits of the extended amygdala can explain the fear response profile during exposure to unpredictable threat. Using fear training with predictable or unpredictable cues in mice, combined with local and cell-type-specific deficiency and rescue of cannabinoid type 1 (CB1) receptors, we found that presynaptic CB1 receptors on distinct amygdala projections to bed nucleus of the stria terminalis (BNST) are both necessary and sufficient for the shift from phasic to sustained fear in response to an unpredictable threat. These results thereby identify the causal role of a defined protein in a distinct brain pathway for the temporal development of a sustained state of anxious apprehension during unpredictability of environmental influences, reminiscent of anxiety symptoms in humans.Molecular Psychiatry advance online publication, 4 October 2016; doi:10.1038/mp.2016.156.
- PMID: 27698427
- DOI: 10.1038/mp.2016.156
- [PubMed – as supplied by publisher]